• Home
  • News

Sichenzia Ross Ference LLP Represents Biotricity in $15.15 Million Underwritten Public Offering and NASDAQ Uplisting

biotricity logo

Press Release – New York, NY – August 31, 2021 – Sichenzia Ross Ference LLP today announced that it represented Biotricity, Inc. (NASDAQ: BTCY), a medical diagnostic and consumer healthcare technology company, in an underwritten public offering. The offering consisted of 5,000,000 shares (the “Shares”) of common stock, par value $0.001 per share (the “Common Stock”), at a price to the public of $3.00 per Share. The gross proceeds of the offering to the company were approximately $15.15 million including a partial exercise of the overallotment option.

H.C. Wainwright & Co. acted as the sole book-running manager for the offering.

The Sichenzia Ross Ference LLP team was led by partners Gregory Sichenzia, David Manno, Marcelle Balcombe and associates Rajiv Radia and Ryan Houseal.

Sichenzia Ross Ference LLP
Latest posts by Sichenzia Ross Ference LLP (see all)